Henit Yanai is an expert in Gastroenterology at Rabin Medical Center (Israel). As of October 2026, ScienceLeadR ranks Henit Yanai in the top 1% of experts worldwide for Inflammatory Bowel Diseases and Gastroenteritis. Henit Yanai has authored 296 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 2 of them ongoing. SLR score: 1,154 (community average: 125). How the SLR is computed.

LeadR Profile

Henit Yanai Rabin Medical Center Israel
1 154 ScienceLeadR Reputation 1154
Network Map

Gastroenterology

Subspecialties: Nutrition - Hepatology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2011 - 2026

Source: PubMed

Tel Aviv University

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Microbial predictors of sustained clinical remission following the Crohn's disease exclusion diet in adults and microbiome shifts toward healthy pediatric controls.
PMID 42491760 — genes, crohn disease, diet, therapeutics, gastrointestinal microbiome
Crohns Colitis 36020262
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.
PMID 42417116 — opportunistic infections, vaccines, vaccination, inflammatory bowel diseases, diagnosis, colitis, ulcerative, infections
J Crohns Colitis20267
Aligning patient and planetary health: planetary health diet adherence and inflammatory bowel disease prognosis across Western and Eastern cohorts.
PMID 42373652 — carbon footprint, algorithms, diet, inflammatory bowel diseases, prognosis
NPJ Sci Food20261
Combined acetaldehyde metabolism burden modifies IBD susceptibility to alcohol consumption.
PMID 42309807 — acetaldehyde, oxidoreductases, gastroenterology, aldehydes, metabolomics, aldehyde dehydrogenase, alcohol drinking, wine
Gut20262
Randomized Trial of Intensive Nurse-Led Follow‑Up Versus Standard Care in Inflammatory Bowel Disease.
PMID 42228308 — nurses, gastroenterology, inflammatory bowel diseases
Dig Dis Sci20260

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 7
Phase 1/Phase 2 1
Phase 3 1
Phase 4 1

By status:

Completed 4
Unknown 3
Recruiting 2
Not yet recruiting 1

By type:

Interventional 7
Observational 3

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 3
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
AI enabled Endoscopic Prediction of Post operative Recurrence in Crohn s Disease
NCT06505304 — injections, cells, telephone, intelligence, fluorescein, blood, leukocyte l1 antigen complex, crohn disease, colon, biopsy, ileum, machine learning, metagenomics, lasers, endoscopy, research, learning, artificial intelligence, colonoscopy
N/ARecruiting2024
A Smartphone Application for Added Psychological Wellbeing in Crohn s Disease
NCT06221254 — exercise, quality of life, health care costs, crohn disease, stress, physiological, smartphone, mindfulness, research, therapeutics, learning, cognitive behavioral therapy
N/ARecruiting2023

LeadR Networks

Main global connection map